Evidence map›Paper›PMID 24918213›Full record

ReviewPediatrics2014

Treatment setting, clinical trial enrollment, and subsequent outcomes among adolescents with cancer: a literature review.

Eric Tai, Natasha Buchanan, Lauren Westervelt, Dena Elimam, Silvana Lawvere

Abstract readReview
In one paragraph

Review in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Future of Treatment of Adolescents and Young Adults With ALL: A Vision for Collaboration and Equity.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. A Hope-Based Intervention to Address Disrupted Goal Pursuits and Quality of Life Among Young Adult Cancer Survivors.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Adolescent angst: enrollment on clinical trials.Hematology. American Society of Hematology. Education Program · 2018
    Review
  14. Article
  15. Observational
  16. Geographic Access to Cancer Care and Mortality Among Adolescents.Journal of adolescent and young adult oncology · 2018
    Article
  17. Observational
  18. Article
  19. Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric TaiCenters for Disease Control and Prevention, Atlanta, Georgia; etai@cdc.gov.
Natasha BuchananCenters for Disease Control and Prevention, Atlanta, Georgia;
Lauren WesterveltSciMetrika LLC, Research Triangle Park, North Carolina; and.
Dena ElimamSciMetrika LLC, Research Triangle Park, North Carolina; and.
Silvana LawvereDepartment of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, North Carolina.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundThere has been an overall improvement in survival rates for persons with cancer over the past 35 years. However, these gains are less prevalent among adolescents with cancer aged 15 to 19 years, which may be due to lower clinical trial enrollment among adolescents with cancer.

methodsWe conducted a literature review to assess current research regarding clinical trial enrollment and subsequent outcomes among adolescents with cancer. The search included English-language publications that reported original data from January 1985 to October 2011.

resultsThe search identified 539 records. Of these 539 records, there were 30 relevant original research articles. Multiple studies reported that adolescents with cancer are enrolled in clinical trials at lower rates compared with younger children and older adults. Treatment setting, physician type, and institution type may all be factors in the low enrollment rate among adolescents. Few data focused solely on adolescents, with many studies combining adolescents with young adults. The number of available studies related to this topic was limited, with significant variability in study design, methods, and outcomes.

conclusionsThis literature review suggests that adolescents with cancer are not treated at optimal settings and are enrolled in clinical trials at low rates. This may lead to inferior treatment and poor subsequent medical and psychosocial outcomes. The scarcity in data further validates the need for additional research focusing on this population.

Indexed as

Patient SelectionAdolescentClinical Trials as TopicHumansNeoplasmsSurvival RateTreatment OutcomeYoung Adultadolescentscancerclinical trial enrollmentoncology

Identifiers

PMID24918213
PMCPMC6075704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.